Drug Industry Daily
Aug. 28, 2012
| Vol.
11 No.
169
FDA Approves Gilead’s ‘Quad’ Combo Pill for HIV Treatment
The FDA has approved Gilead’s Stribild, previously called Quad, as a once-daily combo pill for treatment-naïve adults with HIV.
This article is viewable by subscribers only. To view this article, please select an option below.
|